Holen Sie sich die Stockscreener-App
13.96
0.00%
0.00
Handel nachbörslich:
13.92
-0.04
-0.29%
Schlusskurs vom Vortag:
$13.96
Offen:
$14.2
24-Stunden-Volumen:
1.14M
Relative Volume:
0.84
Marktkapitalisierung:
$646.97M
Einnahmen:
$217.11M
Nettoeinkommen (Verlust:
$-651.19M
KGV:
-1.0747
EPS:
-12.99
Netto-Cashflow:
$-387.26M
1W Leistung:
+23.32%
1M Leistung:
+47.57%
6M Leistung:
+13.68%
1J Leistung:
-5.73%
1-Tages-Spanne:
$13.60
$14.24
1-Wochen-Bereich:
$11.28
$15.48
52-Wochen-Spanne:
$5.00
$16.85
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Firmenname
Ginkgo Bioworks Holdings Inc
Sektor
Branche
Telefon
(877) 442-5362
Adresse
27 DRYDOCK AVENUE, BOSTON
Vergleichen Sie DNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
13.96 | 817.11M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-15 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-05-10 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-06-02 | Herabstufung | Goldman | Neutral → Sell |
| 2023-05-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | Eingeleitet | Berenberg | Buy |
| 2022-10-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2022-02-23 | Eingeleitet | Goldman | Neutral |
| 2022-02-01 | Eingeleitet | BofA Securities | Neutral |
| 2022-01-28 | Eingeleitet | BofA Securities | Buy |
| 2022-01-07 | Eingeleitet | BTIG Research | Buy |
| 2021-11-29 | Eingeleitet | Jefferies | Buy |
| 2021-10-13 | Eingeleitet | Raymond James | Outperform |
| 2021-10-12 | Eingeleitet | William Blair | Outperform |
| 2021-09-20 | Eingeleitet | HSBC Securities | Buy |
Alle ansehen
Ginkgo Bioworks Holdings Inc Aktie (DNA) Neueste Nachrichten
What is the dividend policy of Ginkgo Bioworks Holdings Inc. stockSwing Trade Updates For Consistent Profits - jammulinksnews.com
What makes Ginkgo Bioworks Holdings Inc. stock price move sharplyMaximize your gains with professional insights - jammulinksnews.com
What are analysts’ price targets for Ginkgo Bioworks Holdings Inc. in the next 12 monthsTake advantage of unprecedented market momentum - jammulinksnews.com
When is Ginkgo Bioworks Holdings Inc. stock expected to show significant growthTop Growth Watchlist For 2025 - jammulinksnews.com
What are the latest earnings results for Ginkgo Bioworks Holdings Inc.Achieve rapid portfolio appreciation today - jammulinksnews.com
What institutional investors are buying Ginkgo Bioworks Holdings Inc. stockAchieve rapid wealth accumulation through smart investing - jammulinksnews.com
Should I hold or sell Ginkgo Bioworks Holdings Inc. stock in 2025Accelerated capital growth - jammulinksnews.com
What catalysts could drive Ginkgo Bioworks Holdings Inc. stock higher in 2025High-octane financial growth - jammulinksnews.com
How strong is Ginkgo Bioworks Holdings Inc. company’s balance sheetPhenomenal trading returns - jammulinksnews.com
Ginkgo Bioworks Stock (DNA) Opinions on New Product Launch and Earnings Anticipation - Quiver Quantitative
Why Ginkgo Bioworks Holdings Inc. stock attracts strong analyst attentionEarly Breakout Tracker - beatles.ru
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know - MSN
What drives Ginkgo Bioworks Holdings Inc. stock priceDynamic investment opportunities - PrintWeekIndia
Is Ginkgo Bioworks Holdings Inc. a good long term investmentPhenomenal wealth increase - PrintWeekIndia
What analysts say about Ginkgo Bioworks Holdings Inc. stockMarket-beating performance - Autocar Professional
How high can Ginkgo Bioworks Holdings Inc. stock price go in 2025Free Stock Market Trend Analysis - jammulinksnews.com
Ginkgo Bioworks Holdings Inc. Stock Analysis and ForecastFree Investment Community - jammulinksnews.com
Ginkgo Bioworks Holdings Earns Relative Strength Rating Upgrade; Hits Key Benchmark - Investor's Business Daily
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Sinks As Market Gains: Here's Why - MSN
Finanzdaten der Ginkgo Bioworks Holdings Inc-Aktie (DNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.32%
1.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):